SEC Filing Details

Form
4
Filing Date
December 21, 2021
Document Date
December 20, 2021
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Atea Pharmaceuticals, Inc.
Issuer
Atea Pharmaceuticals, Inc.
Filer
MURPHY POLLY A.

Atea is a clinical-stage biopharmaceutical company working to address unmet medical needs through novel antiviral treatment.

Copyright © 2024 By Atea Pharmaceuticals, Inc. All Rights Reserved. Privacy Policy | Terms of Use